HCV-replication after liver transplantation: Influence of immunosuppressive therapy.

被引：0
|
作者：
Tisone, G
Angelico, M
Gandin, C
Romagnoli, J
Palmieri, G
Montano, M
Orlando, G
Negrini, S
Pisani, F
Casciani, CU
机构：
[1] UNIV ROMA TOR VERGATA,DEPT SURG,LIVER TRANSPLANT CTR,ROME,ITALY
[2] UNIV ROMA TOR VERGATA,DEPT PATHOL,ROME,ITALY
[3] UNIV ROMA TOR VERGATA,DEPT GASTROENTEROL,ROME,ITALY
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1850 / 1850
页数：1
相关论文
共 50 条
  • [31] The ways to reduce immunosuppressive therapy after living related liver transplantation.
    Tsiroulnikova, OM
    Filin, AV
    Kim, EF
    Semenkov, AV
    Smirnov, EA
    Gautier, SV
    LIVER TRANSPLANTATION, 2005, 11 (07) : C42 - C42
  • [32] ROLE OF IMMUNOSUPPRESSIVE THERAPY ON HISTOLOGICAL HEPATITIS-C VIRUS (HCV) RECURRENCE AFTER LIVER TRANSPLANTATION (LT): A RETROSPECTIVE COHORT DATA
    Meine, Mario H. M. M.
    Zanotelli, Maria Lucia
    Cantisani, Guido P. C.
    Marroni, Claudio A.
    Brandao, Ajacio B. M.
    Schlindwein, Eduardo S.
    Leipnitz, Ian
    Kiss, Guillermo
    Mucenic, Marcos
    Osorio, Marcus V.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S188 - S188
  • [33] Pediatric liver transplantation with daclizumab induction therapy.
    Heffron, TG
    Pillen, T
    Smallwood, GA
    Welch, D
    Oakley, B
    Romero, R
    TRANSPLANTATION, 2003, 75 (12) : 2040 - 2043
  • [34] Combination Therapy with Simeprevir and Sofosbuvir for Genotype 1 HCV after Liver Transplantation
    Ripper, S.
    Holt, E.
    Cooper, S.
    Wakil, A.
    Davern, T.
    Merriman, R.
    Guy, J.
    Frederick, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 154 - 154
  • [35] HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary
    Bunchorntavakul, Chalermrat
    Reddy, Rajender
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (04): : 449 - 452
  • [36] DR antigens influence graft outcome and HCV recurrence after liver transplantation
    Kimball, P
    Stravitz, T
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1099 - 1100
  • [37] Combination Therapy with Simeprevir and Sofosbuvir for Genotype 1 HCV after Liver Transplantation
    Ripper, S.
    Holt, E.
    Cooper, S.
    Wakil, A.
    Davern, T.
    Merriman, R.
    Guy, J.
    Frederick, R.
    TRANSPLANTATION, 2014, 98 : 154 - 154
  • [38] Donor age does not influence progression of HCV recurrence after liver transplantation
    Samonakis, DN
    Triantos, CK
    Thalheimer, U
    Quaglia, A
    Leandro, G
    Papatheodoridis, GV
    Teixeria, R
    Raimondo, ML
    Rolando, N
    Dhillon, AP
    Patch, DW
    Davidson, BR
    Rolles, K
    Burroughs, AK
    JOURNAL OF HEPATOLOGY, 2004, 40 : 6 - 7
  • [39] Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
    Vivarelli, Marco
    Burra, Patrizia
    La Barba, Giuliano
    Canova, Daniele
    Cucchetti, Alessandro
    Senzolo, Marco
    Guido, Maria
    D'Errico, Antonia
    Merenda, Roberto
    Neri, Daniele
    Cillo, Umberto
    Pinna, Antonio D.
    LIVER TRANSPLANTATION, 2007, 13 (06) : S158 - S158
  • [40] Influence or rejection treatment on outcome in patients with HCV related liver disease after liver transplantation
    Neumann, UP
    Langrehr, JM
    Bechstein, WO
    Lang, M
    Neuhaus, P
    TRANSPLANTATION, 1999, 67 (07) : S197 - S197
12345